Head-To-Head Review: Eargo (EAR) and The Competition

Eargo (NASDAQ: EAR) is one of 40 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Eargo to related companies based on the strength of its institutional ownership, valuation, profitability, analyst recommendations, risk, earnings and dividends.

Earnings & Valuation

This table compares Eargo and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Eargo $69.15 million -$39.85 million -10.00
Eargo Competitors $1.11 billion $144.99 million 21.41

Eargo’s competitors have higher revenue and earnings than Eargo. Eargo is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for Eargo and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eargo 0 0 4 0 3.00
Eargo Competitors 300 1214 2127 84 2.54

Eargo currently has a consensus price target of $45.33, indicating a potential upside of 19.33%. As a group, “Surgical appliances & supplies” companies have a potential upside of 2.70%. Given Eargo’s stronger consensus rating and higher probable upside, equities analysts clearly believe Eargo is more favorable than its competitors.

Institutional & Insider Ownership

47.6% of Eargo shares are held by institutional investors. Comparatively, 54.6% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 9.0% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Eargo and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Eargo N/A N/A N/A
Eargo Competitors -217.15% -60.23% -13.89%

About Eargo

Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.

Receive News & Ratings for Eargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eargo and related companies with MarketBeat.com's FREE daily email newsletter.